The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Athersys Inc

Nasdaq: ATHX
Last

(U.S.) $1.15

Today's change+0.01 +0.88%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Athersys Inc

Nasdaq: ATHX
Last

(U.S.) $1.15

Today's change+0.01 +0.88%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Athersys Inc up (U.S.)$0.01

Athersys Inc closed up Friday by (U.S.)$0.01 or 0.88% to (U.S.)$1.15. Over the last five days, shares have lost 1.71% and are down 27.22% for the last year to date. This security has underperformed the S&P 500 by 16.27% during the last year.

Key company metrics

  • Open(U.S.) $1.14
  • Previous close(U.S.) $1.14
  • High(U.S.) $1.17
  • Low(U.S.) $1.13
  • Bid / Ask-- / --
  • YTD % change-27.22%
  • Volume236,424
  • Average volume (10-day)269,139
  • Average volume (1-month)377,513
  • Average volume (3-month)389,991
  • 52-week range(U.S.) $0.90 to (U.S.) $3.43
  • Beta0.24
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.31
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,680.68%

Athersys Inc has a net profit margin of -1,680.68%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue0100
Total other revenue--------
Total revenue0100
Gross profit--------
Total cost of revenue--------
Total operating expense7878
Selling / general / administrative2222
Research & development5666
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-7-7-7-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-12-7-5
Income after tax-1-12-7-5
Income tax, total----0--
Net income-1-12-7-5
Total adjustments to net income--------
Net income before extra. items-1-12-7-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-12-7-5
Inc. avail. to common incl. extra. items-1-12-7-5
Diluted net income-1-12-7-5
Dilution adjustment0------
Diluted weighted average shares83797878
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.16-0.08-0.06
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.01-0.16-0.08-0.06